Felix B.
- Country
- Germany
- Department
- Klinik für Allgemeine, Viszeral-, Thorax-, Transplantations- und Kinderchirurgie
Research Overview
- Evaluation of Cognitive Function Post-Liver Transplantation: A Comparative Study of Once-Daily Versus Twice-Daily Tacrolimus Formulations
- Phase 2 Evaluation of Neoadjuvant Gemcitabine, Cisplatin, Durvalumab, and Tremelimumab in Intrahepatic Cholangiocarcinoma
- Comparative Study of Tacrolimus Bioavailability: Envarsus vs. Advagraf in De Novo Liver Transplant Recipients
Data & Insights
Has run more than one trial at 8 of 15 partner sites.
Specializations
Hepatobiliary Oncology
The investigator specializes in the treatment of intrahepatic cholangiocarcinoma, focusing on innovative therapeutic approaches combining chemotherapy and immunotherapy in the neoadjuvant setting.
- Biliary tract cancers
- Neoadjuvant therapy strategies
- Combined immunotherapy approaches
Special focus on surgical outcomes in biliary tract malignancies.
Transplant Medicine
Expertise in liver transplantation with particular emphasis on immunosuppressive therapy optimization and drug bioavailability in transplant recipients.
- Transplant rejection prevention
- Immunosuppressive drug monitoring
- Post-transplant care
Specialization in tacrolimus-based immunosuppression protocols.
Transplant Neurology
Investigation of cognitive function in liver transplant patients, with particular attention to the neurological effects of different immunosuppressive regimens.
- Cognitive performance assessment
- Memory and attention studies
- Neurological outcomes in transplantation
Focus on quality of life improvements in transplant recipients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.